Authors:
MORETTI JL
CORDOBES MD
STARZEC A
DEBECO V
VERGOTE J
BENAZZOUZ F
BOISSIER B
COHEN H
SAFI N
PIPERNONEUMANN S
KOUYOUMDJIAN JC
Citation: Jl. Moretti et al., INVOLVEMENT OF GLUTATHIONE IN LOSS OF TECHNETIUM-99M-MIBI ACCUMULATION RELATED TO MEMBRANE MDR PROTEIN EXPRESSION IN TUMOR-CELLS, The Journal of nuclear medicine, 39(7), 1998, pp. 1214-1218
Authors:
CORDOBES MD
MORETTI JL
DEBECO V
VERGOTE J
BOISSIER B
STARZEC A
VASSY R
KOUYOUMDJIAN JC
Citation: Md. Cordobes et al., SESTAMIBI TC 99M (MIBI) UPTAKE IN HUMAN CELL-LINES EXHIBITING MULTIDRUG-RESISTANCE RELATED TO MDR OR MRP GENES, The Journal of nuclear medicine, 38(5), 1997, pp. 1069-1069
Authors:
KOTTLER ML
STARZEC A
CARRE MC
LAGARDE JP
MARTIN A
COUNIS R
Citation: Ml. Kottler et al., THE GENES FOR GONADOTROPIN-RELEASING-HORMONE AND ITS RECEPTOR ARE EXPRESSED IN HUMAN BREAST WITH FIBROCYSTIC DISEASE AND CANCER, International journal of cancer, 71(4), 1997, pp. 595-599
Authors:
DEBECO V
MORETTI JL
CORDOBES MD
BENAZZOUZ F
PASQUALINI R
STARZEC A
Citation: V. Debeco et al., UPTAKE OF TC-99M NOET IN CANCER CELL-LINES SENSITIVE (SE) AND RESISTANT (RT) TO CHEMOTHERAPY - COMPARISON WITH TC-99M SESTAMIBI, The Journal of nuclear medicine, 37(5), 1996, pp. 868-868
Authors:
MORETTI JL
CORDOBES MD
DEBECO V
BOISSIER B
KOUYOUMDJI JC
CHEVILLARD S
STARZEC A
Citation: Jl. Moretti et al., TC-99MSESTAMIBI UPTAKE IN HUMAN CANCER CELL-LINES RESISTANT TO CHEMOTHERAPY MEDIATED BY MULTIDRUG-RESISTANCE ASSOCLATED PROTEIN(MRP), The Journal of nuclear medicine, 37(5), 1996, pp. 1051-1051
Authors:
CORDOBES MD
STARZEC A
DELMONMOINGEON L
BLANCHOT C
KOUYOUMDJIAN JC
PREVOST G
CAGLAR M
MORETTI JL
Citation: Md. Cordobes et al., TECHNETIUM-99M-SESTAMIBI UPTAKE BY HUMAN BENIGN AND MALIGNANT BREAST-TUMOR CELLS - CORRELATION WITH MDR GENE-EXPRESSION, The Journal of nuclear medicine, 37(2), 1996, pp. 286-289
Citation: N. Veber et al., EVIDENCE FOR A GROWTH EFFECT OF EPIDERMAL GROWTH-FACTOR ON MDA-MB-231BREAST-CANCER CELLS, European journal of cancer, 30A(9), 1994, pp. 1352-1359
Citation: P. Planchon et al., SELECTION OF A HIGHLY TUMORIGENIC BREAST-CANCER CELL-LINE SENSITIVE TO ESTRADIOL TO EVIDENCE IN-VIVO THE TUMOR-INHIBITORY EFFECT OF BUTYRATE DERIVATIVE MONOBUT-3, Life sciences, 55(12), 1994, pp. 951-959